- Report
- April 2025
- 250 Pages
Global
From €3949EUR$4,490USD£3,442GBP
- Report
- April 2025
- 400 Pages
Global
From €3949EUR$4,490USD£3,442GBP
- Report
- April 2025
- 200 Pages
Global
From €3949EUR$4,490USD£3,442GBP
- Report
- March 2025
- 200 Pages
Global
From €3949EUR$4,490USD£3,442GBP
- Report
- February 2025
- 200 Pages
Global
From €3949EUR$4,490USD£3,442GBP
- Report
- February 2025
- 200 Pages
Global
From €3949EUR$4,490USD£3,442GBP
- Report
- August 2025
- 187 Pages
Global
From €3118EUR$3,545USD£2,718GBP
€3464EUR$3,939USD£3,019GBP
- Report
- November 2025
- 150 Pages
Global
From €2638EUR$3,000USD£2,300GBP
€3298EUR$3,750USD£2,875GBP
- Report
- November 2025
- 150 Pages
Global
From €2638EUR$3,000USD£2,300GBP
€3298EUR$3,750USD£2,875GBP
- Report
- June 2025
- 400 Pages
Global
From €4352EUR$4,949USD£3,794GBP
- Report
- June 2025
- 271 Pages
Global
From €4393EUR$4,995USD£3,829GBP
- Report
- October 2025
- 160 Pages
Global
From €2953EUR$3,358USD£2,574GBP
€3474EUR$3,950USD£3,028GBP
- Report
- April 2025
- 104 Pages
Global
From €3500EUR$4,263USD£3,158GBP
- Report
- March 2025
- 89 Pages
Global
From €3500EUR$4,263USD£3,158GBP
- Report
- January 2025
- 81 Pages
Global
From €3500EUR$4,263USD£3,158GBP
- Report
- December 2025
- 150 Pages
Global
From €3386EUR$3,850USD£2,951GBP
- Report
- July 2025
- 150 Pages
Global
From €3386EUR$3,850USD£2,951GBP
€4265EUR$4,850USD£3,718GBP
- Report
- June 2025
- 150 Pages
Global
From €3386EUR$3,850USD£2,951GBP
€4265EUR$4,850USD£3,718GBP
- Report
- April 2025
- 150 Pages
Global
From €3386EUR$3,850USD£2,951GBP
€4265EUR$4,850USD£3,718GBP
- Report
- September 2025
- 200 Pages
North America
From €2190EUR$2,490USD£1,909GBP

The Artificial Heart market is a subset of the Cardiovascular Devices market, which includes a variety of medical devices used to treat heart conditions. Artificial Hearts are mechanical devices that are implanted into a patient's body to replace a failing heart. These devices are typically used as a bridge to heart transplantation, providing a temporary solution for patients with end-stage heart failure. Artificial Hearts are designed to mimic the natural functions of the heart, such as pumping blood and regulating blood pressure.
The Artificial Heart market is highly competitive, with a number of companies offering a range of products. Companies in the market include Abiomed, SynCardia Systems, Carmat, and WorldHeart Corporation. These companies are focused on developing innovative Artificial Heart technologies to improve patient outcomes and reduce healthcare costs. Show Less Read more